NextCure, Inc.
NXTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55,654 | -$62,723 | -$74,733 | -$69,389 |
| Dep. & Amort. | $2,865 | $3,684 | $4,124 | $7,196 |
| Deferred Tax | $0 | $0 | $0 | -$23,743 |
| Stock-Based Comp. | $6,335 | $8,188 | $9,508 | $10,288 |
| Change in WC | $4,532 | -$1,940 | $3,725 | -$5,339 |
| Other Non-Cash | $1,117 | -$183 | $3,490 | $23,743 |
| Operating Cash Flow | -$40,805 | -$52,974 | -$53,886 | -$57,244 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$474 | -$820 | -$2,116 | -$2,360 |
| Net Acquisitions | $0 | $0 | -$70 | -$39 |
| Inv. Purchases | -$48,448 | -$73,505 | -$34,644 | -$156,477 |
| Inv. Sales/Matur. | $104,228 | $113,597 | $104,739 | $195,438 |
| Other Inv. Act. | $0 | $0 | $70 | $39 |
| Investing Cash Flow | $55,306 | $39,272 | $67,979 | $36,601 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$3,473 |
| Stock Issued | $39 | $154 | $200 | $208 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $105 | $0 | $0 | $0 |
| Financing Cash Flow | $144 | $154 | $200 | -$3,265 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $14,645 | -$13,548 | $14,293 | -$23,908 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,082 | $26,630 | $12,337 | $36,284 |
| End Cash | $27,727 | $13,082 | $26,630 | $12,376 |
| Free Cash Flow | -$41,279 | -$53,794 | -$56,002 | -$59,604 |